Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

33.10
Delayed Data
As of Sep 04
 -0.41 / -1.22%
Today’s Change
18.23
Today|||52-Week Range
42.48
+67.17%
Year-to-Date

Today’s Trading

Previous close33.51
Today’s open32.96
Day’s range32.25 - 34.22
Volume147,906
Average volume (3 months)324,016
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+34.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio146.0
Price/Sales10.36
Price/Book9.71

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.09+1.47%
SCMPSucampo Pharmaceutic...+0.42+1.75%
DVAXDynavax Technologies...+0.45+1.62%
MACKMerrimack Pharmaceut...-0.32-3.14%
Data as of 4:01pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers